Reuters logo
BRIEF-Shanghai RAAS Blood Products unit sells Hubei-based pharma firm for 238 mln yuan
May 3, 2017 / 8:53 AM / 7 months ago

BRIEF-Shanghai RAAS Blood Products unit sells Hubei-based pharma firm for 238 mln yuan

May 3 (Reuters) - Shanghai RAAS Blood Products Co Ltd :

* Says its Zhengzhou unit has transferred Hubei-based pharma company to a Shenzhen investment company, for 238 million yuan

Source text in Chinese: goo.gl/CYMnx1

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below